Rogers Evan R, Sankarasubramanian Vishwanath, Kyi Wutt Hmone T, Mirzakhalili Ehsan, Anaya Carlos J, Loechli Jessica, Harte Steven E, Patil Parag G, Chiravuri Srinivas, Lempka Scott F
Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA.
J Pain Res. 2025 Aug 29;18:4455-4470. doi: 10.2147/JPR.S519187. eCollection 2025.
The analgesic mechanisms and neurophysiological effects of spinal cord stimulation (SCS) and dorsal root ganglion stimulation (DRGS) are poorly understood. In this pilot repeated-measures study, we used quantitative sensory testing (QST) and self-reported questionnaires to investigate the effects of these therapies in chronic pain patients from pre-implantation up to one-year post-implantation. Several studies have reported stimulation-induced effects on QST, potentially clarifying how neurostimulation affects the nervous system, which is poorly understood. This pilot study aimed to probe chronic stimulation-induced changes using a wide battery of static and dynamic QST assessments as a precursor to future, larger studies.
We enrolled 33 chronic pain patients selected as candidates for SCS and DRGS at pre-implantation and at three intervals up to at least 12 months post-implantation, with 18 completing at least one post-implantation visit. At each visit, we evaluated static (pressure-pain and vibration sensitivity) and dynamic (temporal summation, conditioned pain modulation) QST measures and patients self-reported pain-related clinical outcomes.
Subjects reported significant improvements in pain severity, pain interference, pain disability, sensory and affective pain indices, sleep interference, depression, and general health at all post-implantation timepoints, as well as non-significant improvements in anxiety and coping. QST results typically failed to reach statistical significance. However, non-significant trends were observed for various stimulation-induced physiological effects, notably including reduced temporal summation at the primary pain site that was not observed at a non-painful control site.
This exploratory study demonstrates that SCS and DRGS produce meaningful therapeutic and clinical benefits up to at least one-year post-implantation and may modulate somatosensory processing. However, caution in extrapolating results is warranted due to appreciable attrition, heterogeneous patient population, and the lack of a control group. Additional studies will be necessary to evaluate whether clinical improvements are maintained beyond one year as well as confirm potential QST trends.
脊髓刺激(SCS)和背根神经节刺激(DRGS)的镇痛机制及神经生理效应尚不清楚。在这项初步的重复测量研究中,我们使用定量感觉测试(QST)和自我报告问卷,来研究这些疗法对慢性疼痛患者从植入前到植入后一年的影响。多项研究报告了刺激对QST的影响,这可能有助于阐明神经刺激如何影响知之甚少的神经系统。这项初步研究旨在通过一系列广泛的静态和动态QST评估,探究慢性刺激引起的变化,为未来更大规模的研究做准备。
我们招募了33名慢性疼痛患者,他们在植入前以及植入后长达至少12个月的三个时间点被选为SCS和DRGS的候选对象,其中18人完成了至少一次植入后的随访。每次随访时,我们评估静态(压痛和振动敏感性)和动态(时间总和、条件性疼痛调制)QST指标,以及患者自我报告的疼痛相关临床结果。
受试者报告在所有植入后的时间点,疼痛严重程度、疼痛干扰、疼痛残疾、感觉和情感疼痛指数、睡眠干扰、抑郁和总体健康状况都有显著改善,焦虑和应对方面也有不显著的改善。QST结果通常未达到统计学显著性。然而,观察到了各种刺激引起的生理效应的不显著趋势,特别是在主要疼痛部位的时间总和减少,而在非疼痛对照部位未观察到这种情况。
这项探索性研究表明,SCS和DRGS在植入后至少一年内产生了有意义的治疗和临床益处,并且可能调节体感处理。然而,由于明显的损耗、患者群体的异质性以及缺乏对照组,在推断结果时需要谨慎。需要进一步的研究来评估临床改善是否能维持超过一年,并确认潜在的QST趋势。